MaaT Pharma Receives Negative CHMP Trend Vote for MaaT013 (Xervyteg®) Following Re-Examination for its Conditional Marketing Authorization Application in Europe

Posted on by sHq_LoGiNz

LYON, France–(BUSINESS WIRE)—- $MAAT–MaaT Pharma Receives Negative CHMP Trend Vote for MaaT013 Following Re-Examination for its Conditional Marketing Authorization Application in Europe

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.